Evaluation of antimicrobial activity of ipomoea fistulosa, furcreae foetida and Barleria mysorensis: An in vitro study

Research Journal of Pharmacy and Technology

Volumn 5, Issue 8, 2012, Pages 1081-1084

  Mazumdar, Akash ^a   Gurung, Neelam ^a   Phulera, Sumit ^a   Mathew, Jinsu ^a   Kumar, Gaurav ^a   Karthik, Loganathan ^a   Rao, Kokati Venkata Bhaskara ^a  

^a VIT UNIVERSITY   (India)

Author keywords

Antimicrobial activity; Barleria mysorensis; Furcraea foetida; Ipomoea fistulosa; Minimum inhibitory concentration

Indexed keywords

BARLERIA MYSORENSIS EXTRACT; CHLORAMPHENICOL; ERYTHROMYCIN; FLUCONAZOLE; FURCREAE FOETIDA EXTRACT; IPOMOEA FISTULA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; VANCOMYCIN;

ACANTHACEAE; AGAR DIFFUSION; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPARAGACEAE; BARLERIA MYSORENSIS; CANDIDA ALBICANS; CANDIDA TROPICALIS; DRUG EFFICACY; DRUG SCREENING; ENZYME INHIBITION; ESCHERICHIA COLI; FURCREAE FOETIDA; HUMAN; HUMAN CELL; IN VITRO STUDY; IPOMOEA; IPOMOEA FISTULA; KLEBSIELLA PNEUMONIAE; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; PLANT LEAF; PROTEUS MIRABILIS; SALMONELLA TYPHI; SPECIES DIFFERENTIATION; STAPHYLOCOCCUS AUREUS;

EID: 84866849517     PISSN: 0974360X     EISSN: 09743618     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. WHO, Leading Cause of death. 1999. Available from: URL: http://www.who.int/infectious-disease-report/pages/graph1.html.
2. Hsueh PR et al. Antimicrobial drug resistance in pathogens causing nosocomial infections at a University Hospital in Taiwan, 1981-1999. Emerging Infectious Disease. 8 (1); 2002: 63-68.
3. Davis J. Inactivation of antibiotic and the dissemination of resistance genes. Science. 264 (5157); 1994: 375-382.
4. Gonzalez CE et al. Risk factors for fungemia in children infected with human immunodeficiency virus: a case-control study. Clinical Infectious Diseases. 23 (3); 1996: 515-521.
5. Jain R, Jain N, Jain S. Evaluation of anti-inflammatory activity of Ipomoea fistulosa Linn. Asian Journal of Pharmaceutical and Clinical Research. 2(1); 2009: 64-67.
6. Reza MS et al. In vitro antimicrobial activity of Ipomoea fistulosa. Fitoterapia. 65 (5); 1994: 465-466.
7. Abdelhadi AA et al. Neuromuscular blocking activity of a crude aqueous extract of Ipomoea fistulosa. Clinical and Experimental Pharmacology and Physiology. 13 (2); 1986: 169-171.
8. Chowdhury AKA, Ali MS, Khan MOF. Antimicrobial activity of Ipomoea fistulosa extractives. Fitoterapia 68 (4); 1997: 379-380.
9. Yokosuka A et al. Steroidal glycosides from Furcraea foetida and their cytotoxic activity. Chemical and Pharmaceutical Bulletin (Tokyo). 57 (10); 2009: 1161-1166.
10. Poongodi A. et al. Observations on some ethnomedicinal plants in Sathyamangalam forests of Erode district, Tamil Nadu, India. Journal of Medicinal Plants Research. 5 (19); 2011: 4709-4714.
11. Kumar G, Karthik L, Rao KVB. Antibacterial activity of aqueous extract of Calotropis gigantea leaves-an in vitro study. International Journal of Pharmaceutical Sciences Review and Research. 4 (2); 2010: 141-144.
12. Kumar G, Karthik L, Rao KVB. In vitro anti-Candida activity of Calotropis gigantea against clinical isolates of Candida. Journal of Pharmacy Research. 3(3); 2010: 539-542.
13. Ajay KK, Lokanatha RMK, Umesha KB. Evaluation of antibacterial activity of 3,5-dicyano-4,6-diaryl-4-ethoxycarbonyl-piperid-2-ones. Journal of Pharmaceutical and Biomedical Analysis. 27 (5); 2002: 837-840.
14. Okunji CO et al. An antifungal saponin from fruit pulp of Dracaena manni. International Journal of Crude Drug Research. 28 (3); 1990: 193-199.